Valentis Advisors

Jump to

Pricing pressure easing, pharma ripe for recovery: Jyoti Jaipuria

The pharmaceutical sector, recovering from a challenging period, is now on the upswing said Jyotivardhan Jaipuria. Jaipuria's optimism stems from both the sector's bounce back after a difficult year and the stabilization of pricing pressures in the US generic market.
Buy domestic stocks but avoid global-facing ones: Jyotivardhan Jaipuria

“So play where the growth is,” Jaipuria believes.
Favour domestic-oriented stocks, avoid global plays: Valentis Advisors founder Jyotivardhan Jaipuria

Talking about risks, Jaipuria said that by looking at markets, one can say that this is going to be the year of consolidation

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Valentis Advisors

Pricing pressure easing, pharma ripe for recovery: Jyoti Jaipuria

Buy domestic stocks but avoid global-facing ones: Jyotivardhan Jaipuria

Favour domestic-oriented stocks, avoid global plays: Valentis Advisors founder Jyotivardhan Jaipuria